MFN2 and ovarian cancer: We quantified MSL, HE4 and CA125 in pre-operative urine samples in a retrospective cohort of n=192 clinically documented ovarian cancer patients using Lumipulse® G chemiluminescent enzyme immunoassays and correlated these data with matched serum values of each parameter, as determined previously (9).